Renalytix AI (RNLX)
(Delayed Data from NSDQ)
$0.25 USD
0.00 (-1.15%)
Updated Jul 3, 2024 12:53 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RNLX 0.25 0.00(-1.15%)
Will RNLX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for RNLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RNLX
New Strong Buy Stocks for October 26th
What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock
RNLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for October 12th
Renalytix AI PLC Sponsored ADR (RNLX) Loses -44.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Momentive (MNTV) Surges 10.1%: Is This an Indication of Further Gains?
Other News for RNLX
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
Renalytix AI’s KidneyIntelX Gains Medicare Coverage Approval
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
Renalytix announces Medicare issued coverage determination for kidneyintelX.dkd
Renalytix AI Appoints Joel R. Jung as Interim CFO